tirzepatide and afib GLP-1 receptor agonists, including semaglutide (Wegovy/Ozempic) (Mounjaro/Zepbound), are being recognized for benefits beyond blood sugar control and weight management. New real-world evidence suggests they may also play a role in glp-1 miami New research from
Description
If you're on a GLP-1 medication, it's worth knowing that alcohol is high in calories and can cause blood sugar levels to spike and crash
These differences limit the ability to make assumptions about the consistency of clinical benefit in older T2D populations at high CV risk
Cheng AYY
Retatrutide at 1mg once weekly for the first two weeks, then 2mg once weekly for weeks three and four
Weight loss itself reduces AFib burden: studies demonstrate that losing 10% of body weight significantly decreases arrhythmia frequency and symptom severity in overweight AFib patients
